908 Devices (MASS) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Apr, 2026Executive summary
The 2026 Annual Meeting will be held virtually on June 11, 2026, with voting on director elections, auditor ratification, executive compensation, and the frequency of future say-on-pay votes.
Stockholders of record as of April 16, 2026, are eligible to vote; 37,446,534 shares of common stock are outstanding and entitled to vote.
Proxy materials are primarily distributed electronically to reduce costs and environmental impact, with printed copies available upon request.
Voting matters and shareholder proposals
Election of three Class III directors to serve until the 2029 annual meeting.
Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote on executive compensation (say-on-pay).
Advisory vote on the frequency of future say-on-pay votes, with the board recommending annual votes.
Procedures for submitting shareholder proposals and director nominations for future meetings are detailed, with specific deadlines and requirements.
Board of directors and corporate governance
Board consists of nine directors, with a majority qualifying as independent under Nasdaq rules.
Directors are divided into three classes with staggered three-year terms.
Committees include audit, compensation, and nominating/corporate governance, each with defined charters and responsibilities.
Stock ownership policy requires directors and executives to hold specified multiples of salary or retainer in company stock.
Insider trading, hedging, and pledging of company stock are restricted by policy.
Latest events from 908 Devices
- Transformation and innovation drive strong growth outlook, with profitability in near sight.MASS
Sidoti March Small-Cap Virtual Conference29 Apr 2026 - Virtual annual meeting set for June 11, 2026, with key votes on directors and compensation.MASS
Proxy filing29 Apr 2026 - Strong growth, innovation, and global expansion set the stage for profitability by 2027.MASS
Leerink Global Healthcare Conference 20269 Mar 2026 - Up to $100 million in securities to fund growth in handheld chemical analysis markets.MASS
Registration Filing9 Mar 2026 - Handheld detection tools, new products, and software drive growth and recurring revenue in 2026.MASS
TD Cowen 46th Annual Health Care Conference4 Mar 2026 - 2025 revenue rose 18% to $56.2M, margins hit 57%, and Q4 Adjusted EBITDA turned positive.MASS
Q4 20253 Mar 2026 - Q2 revenue up 16% to $14M; 2024 outlook reaffirmed at $63–$65M, with strong handheld growth.MASS
Q2 20242 Feb 2026 - Handheld growth, RedWave integration, and innovation set the stage for future acceleration.MASS
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - RedWave acquisition and product innovation drive growth, margin gains, and market expansion.MASS
The 44th Annual William Blair Growth Stock Conference31 Jan 2026